Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age25-65
SponsorWashington University School of Medicine
About this trial
This study is testing and implementing an equity-focused, community-based intervention that improves women's access to cervical cancer screening and adherence to follow up after an abnormal result. The study's objective is to assess and compare the feasibility of different methods of distributing at-home HPV testing kits for cervical cancer screening among individuals who are under-screened.
Eligibility criteria
Qualifiers
Are age 25-65
Has an intact cervix
Self-reports that they have not been screened for cervical cancer within the last 3 years
Has a smartphone
Disqualifiers
Abnormal vaginal bleeding or discharge
A history of cancer of the reproductive system
A compromised immune system
Prior Diethylstilbestrol (DES) exposure
Trial design
Treatments tested in this trial
- Qualitative Interview
- Virtual Visit Standard Instructions
- Virtual Visit Standard Instructions + In-Person Registration Navigation
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Washington University School of Medicine
Lead sponsor
Teal Health, Inc.
Collaborator
Source ClinicalTrials.gov